Journal article
663P Safety and preliminary efficacy of the KRAS G12C Inhibitor MK-1084 in solid tumors and in combination with pembrolizumab in NSCLC
Authors
Rojas C; Lugowska I; Juergens R; Sacher A; Weindler S; Sendur MAN; Dziadziuszko R; Pal A; Alvarez EC; Ahern ES
Journal
Annals of Oncology, Vol. 34, , pp. s466–s467
Publisher
Elsevier
Publication Date
October 1, 2023
DOI
10.1016/j.annonc.2023.09.1849
ISSN
0923-7534